Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
{{output}}
The treatment of hepatocellular carcinoma (HCC), particularly advanced HCC, has been a serious challenge. Immune checkpoint inhibitors (ICIs) are landmark drugs in the field of cancer therapy in recent years, which have changed the landscape of cancer treatmen... ...
